BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 28314541)

  • 1. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
    Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
    Rabbani F; Reuter VE; Katz J; Russo P
    Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.
    Murray KS; Zabor EC; Spaliviero M; Russo P; Bazzi WM; Musser JE; Ari Hakimi A; Bernstein ML; Dalbagni G; Coleman JA; Furberg H
    World J Urol; 2016 Dec; 34(12):1667-1672. PubMed ID: 27106493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
    Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
    Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.
    Murphy JD; Ma GL; Baumgartner JM; Madlensky L; Burgoyne AM; Tang CM; Martinez ME; Sicklick JK
    Cancer; 2015 Sep; 121(17):2960-7. PubMed ID: 25930983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
    Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis.
    Abdel-Rahman O; Cheung WY
    Curr Med Res Opin; 2017 Nov; 33(11):2009-2017. PubMed ID: 28532174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
    Czene K; Hemminki K
    J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
    Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
    Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple primary malignancies in renal cell carcinoma.
    Rabbani F; Grimaldi G; Russo P
    J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.